The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
4 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $10,354,213 in first-year total cost, median $2,521,939.
Most frequent study sections
- Special Emphasis Panel[ZCA1 RTRB-E (A1)]4
Most frequent institutions
- UNIVERSITY OF TX MD ANDERSON CAN CTR1
- UNIVERSITY OF UTAH1
- WASHINGTON UNIVERSITY1
- WISTAR INSTITUTE1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2017 | Rational approaches to melanoma therapy1U54CA224070-01 | DAVIES, MICHAELHERLYN, MEENHARD F | WISTAR INSTITUTE, PA | $2,885,586 | ZCA1 |
| 2017 | University of Texas PDX Development and Trial Center1U54CA224065-01 | MERIC-BERNSTAM, FUNDAROTH, JACK | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $2,561,686 | ZCA1 |
| 2017 | PDX Trial Center for Breast Cancer Therapy1U54CA224076-01 | LEWIS, MICHAEL T.WELM, ALANA LWELM, BRYAN E. | UNIVERSITY OF UTAH, UT | $2,482,191 | ZCA1 |
| 2017 | Washington University PDX Development and Trial Center1U54CA224083-01 | DING, LIGOVINDAN, RAMASWAMYLI, SHUNQIANG | WASHINGTON UNIVERSITY, MO | $2,424,750 | ZCA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-11-0.1.2. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.